Overview
Sciencepharma is a Polish company founded in 2004 that provides consulting and import services to the pharmaceutical industry. It supports medicinal product development from early stages through registration and lifecycle maintenance, including regulatory affairs, clinical trials and pharmacovigilance, and has prepared over 1,200 registration dossiers. It also specializes in importing medicinal products and investigational medicinal products and in QP batch release under GMP/GDP requirements.
Financials
Revenue history (in m)
Financial insight
- companies.financials.estonianCitCertain
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2007-07-05. Active
16 1240 5934 1111 0011 0482 4862
54 1020 1026 0000 1802 0669 8775- 39 1020 1068 0000 1502 0197 2785
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 33,963PLN 33,963 |
Public aid
5 public aid cases recorded, with a total value of $923,175.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 12, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $898$898 | Prezydent Miasta Stołecznego Warszawy | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $16,416$16,416 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $17,196$17,196 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The declarations of will may be made by the President of the Management Board independently, by two members of the management board jointly, or by an independent commercial proxy independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Qbd Growth Bv | 1,000 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $160,174,284.28 | anpharm.pl | ||
| Biofarmsp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| Farmak Internationalsp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| Synoptis Pharmasp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| BiotonS.A. | $71,777,247.61 | bioton.com | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $40,633,950.51 | biomed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-03 | PKD change (Removed: 68.10.Z, 69.20.Z, 70.22.Z, 72.19.Z, 96.09.Z; Added: 68.11.Z, 70.20.Z, 72.10.Z, 96.99.Z) | |
| 2022-03-02 | Entered in the register |
FAQ
Last updated: 2026-10-07